After excluding cytotoxic drug hits from our analysis, only rucaparib and rimonabant showed potent inhibition of both SARS-2-S and SARS-1-S pseudovirus infection of 293T-ACE2-TMPRSS2 cells. This evidence concerns the gene TMPRSS2 and severe acute respiratory syndrome.